NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDImatinib Gilvec® Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Imatinib Imatinib [Specialist Drug] Malignant Disease, Targeted Therapy Responsive Malignancy, Antineoplastic Drugs Protein Kinase Inhibitors
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA209: Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib
NICE TA326: Imatinib for the adjuvant treatment of gastrointestinal stromal tumours
NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
NICE TA425: Dasatinib, nilotinib and high-dose imatinib for treating resistant CML
NICE TA426: Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
NICE TA426: Dasatinib, nilotinib and imatinib for untreated CML
NICE TA426: Dasatinib, nilotinob and imatinib for untreated CML
NICE TA70: Leukaemia (chronic myeloid) - imatinib
NICE TA86: Gastro-intestinal stromal tumours (GIST) - imatinib